150 related articles for article (PubMed ID: 15943989)
1. Division of pedicles by stapling during cytoreductive surgery for ovarian cancer.
Eisenkop SM; Spirtos NM
Gynecol Oncol; 2005 Jun; 97(3):852-7. PubMed ID: 15943989
[TBL] [Abstract][Full Text] [Related]
2. Morbidity of rectosigmoid resection and primary anastomosis in patients undergoing primary cytoreductive surgery for advanced epithelial ovarian cancer.
Mourton SM; Temple LK; Abu-Rustum NR; Gemignani ML; Sonoda Y; Bochner BH; Barakat RR; Chi DS
Gynecol Oncol; 2005 Dec; 99(3):608-14. PubMed ID: 16153697
[TBL] [Abstract][Full Text] [Related]
3. Splenectomy in the context of primary cytoreductive operations for advanced epithelial ovarian cancer.
Eisenkop SM; Spirtos NM; Lin WC
Gynecol Oncol; 2006 Feb; 100(2):344-8. PubMed ID: 16202446
[TBL] [Abstract][Full Text] [Related]
4. Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach.
Chi DS; Franklin CC; Levine DA; Akselrod F; Sabbatini P; Jarnagin WR; DeMatteo R; Poynor EA; Abu-Rustum NR; Barakat RR
Gynecol Oncol; 2004 Sep; 94(3):650-4. PubMed ID: 15350354
[TBL] [Abstract][Full Text] [Related]
5. The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns.
Park JY; Seo SS; Kang S; Lee KB; Lim SY; Choi HS; Park SY
Gynecol Oncol; 2006 Dec; 103(3):977-84. PubMed ID: 16837030
[TBL] [Abstract][Full Text] [Related]
6. Transverse colectomy in ovarian cancer surgical cytoreduction: operative technique and clinical outcome.
Bristow RE; Peiretti M; Zanagnolo V; Salani R; Giuntoli RL; Maggioni A
Gynecol Oncol; 2008 Jun; 109(3):364-9. PubMed ID: 18396322
[TBL] [Abstract][Full Text] [Related]
7. The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer.
Eisenhauer EL; Abu-Rustum NR; Sonoda Y; Levine DA; Poynor EA; Aghajanian C; Jarnagin WR; DeMatteo RP; D'Angelica MI; Barakat RR; Chi DS
Gynecol Oncol; 2006 Dec; 103(3):1083-90. PubMed ID: 16890277
[TBL] [Abstract][Full Text] [Related]
8. What are the current surgical objectives, strategies, and technical capabilities of gynecologic oncologists treating advanced epithelial ovarian cancer?
Eisenkop SM; Spirtos NM
Gynecol Oncol; 2001 Sep; 82(3):489-97. PubMed ID: 11520145
[TBL] [Abstract][Full Text] [Related]
9. Aggressive surgical strategies in advanced ovarian cancer: a monocentric study of 203 stage IIIC and IV patients.
Colombo PE; Mourregot A; Fabbro M; Gutowski M; Saint-Aubert B; Quenet F; Gourgou S; Rouanet P
Eur J Surg Oncol; 2009 Feb; 35(2):135-43. PubMed ID: 18289825
[TBL] [Abstract][Full Text] [Related]
10. Regional blood flow occlusion during extensive pelvic procedures for ovarian cancer: a randomized trial.
Eisenkop SM; Spirtos NM; Lin WM; Rafidi F; Gross GM
Int J Gynecol Cancer; 2004; 14(4):699-705. PubMed ID: 15304173
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease.
Hou JY; Kelly MG; Yu H; McAlpine JN; Azodi M; Rutherford TJ; Schwartz PE
Gynecol Oncol; 2007 Apr; 105(1):211-7. PubMed ID: 17239941
[TBL] [Abstract][Full Text] [Related]
12. Colon resection for ovarian cancer: intraoperative decisions.
Hoffman MS; Zervose E
Gynecol Oncol; 2008 Nov; 111(2 Suppl):S56-65. PubMed ID: 18835022
[TBL] [Abstract][Full Text] [Related]
13. Extended cytoreduction of intraabdominal metastatic ovarian cancer in the left upper quadrant utilizing en bloc resection.
Hoffman MS; Tebes SJ; Sayer RA; Lockhart J
Am J Obstet Gynecol; 2007 Aug; 197(2):209.e1-4; discussion 209.e4-5. PubMed ID: 17689654
[TBL] [Abstract][Full Text] [Related]
14. Secondary cytoreductive surgery including rectosigmoid colectomy for recurrent ovarian cancer: operative technique and clinical outcome.
Bristow RE; Peiretti M; Gerardi M; Zanagnolo V; Ueda S; Diaz-Montes T; Giuntoli RL; Maggioni A
Gynecol Oncol; 2009 Aug; 114(2):173-7. PubMed ID: 19482344
[TBL] [Abstract][Full Text] [Related]
15. Modified posterior exenteration for ovarian cancer.
Eisenkop SM; Nalick RH; Teng NN
Obstet Gynecol; 1991 Nov; 78(5 Pt 1):879-85. PubMed ID: 1923216
[TBL] [Abstract][Full Text] [Related]
16. The role of bowel surgery with cytoreduction for epithelial ovarian cancer.
Cai HB; Zhou YF; Chen HZ; Hou HY
Clin Oncol (R Coll Radiol); 2007 Dec; 19(10):757-62. PubMed ID: 17889517
[TBL] [Abstract][Full Text] [Related]
17. Cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma.
Tebes SJ; Sayer RA; Palmer JM; Tebes CC; Martino MA; Hoffman MS
Gynecol Oncol; 2007 Sep; 106(3):482-7. PubMed ID: 17590420
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of low anterior en bloc resection as part of cytoreductive surgery for patients with ovarian cancer.
Obermair A; Hagenauer S; Tamandl D; Clayton RD; Nicklin JL; Perrin LC; Ward BG; Crandon AJ
Gynecol Oncol; 2001 Oct; 83(1):115-20. PubMed ID: 11585422
[TBL] [Abstract][Full Text] [Related]
19. The impact of bulky upper abdominal disease cephalad to the greater omentum on surgical outcome for stage IIIC epithelial ovarian, fallopian tube, and primary peritoneal cancer.
Zivanovic O; Eisenhauer EL; Zhou Q; Iasonos A; Sabbatini P; Sonoda Y; Abu-Rustum NR; Barakat RR; Chi DS
Gynecol Oncol; 2008 Feb; 108(2):287-92. PubMed ID: 17996927
[TBL] [Abstract][Full Text] [Related]
20. A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma.
Chi DS; Zivanovic O; Palayekar MJ; Eisenhauer EL; Abu-Rustum NR; Sonoda Y; Levine DA; Leitao MM; Brown CL; Barakat RR
Gynecol Oncol; 2009 Jan; 112(1):6-10. PubMed ID: 19100916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
